Treatment with Neurokinin-1 Receptor Antagonist Reduces Severity of Inflammatory Bowel Disease Induced byCryptosporidium parvum
Authors:
Open Access
- 1 March 2002
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 9 (2) , 333-340
Abstract
Inflammatory bowel disease (IBD) is a chronic, debilitating disorder of uncertain and perhaps multiple etiologies. It is believed to be due in part to disregulation of the immune system. Neuroimmune interactions may be involved in induction or maintenance of IBD. In the present study, we examined the potential role of a neurotransmitter, substance P, in a mouse model of IBD. We found that binding sites for substance P, and more specifically, neurokinin-1 receptors, were upregulated in intestinal tissue of mice with IBD-like syndrome. Dosing of mice with LY303870, a neurokinin-1 receptor antagonist, reduced the severity of IBD, and treatment of mice with preexisting IBD allowed partial healing of lesions. We hypothesize that blocking the binding of substance P to the neurokinin-1 receptor interrupts the inflammatory cascade that triggers and maintains intestinal lesions of IBD.Keywords
This publication has 43 references indexed in Scilit:
- Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisationGut, 2000
- Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis.Journal of Clinical Investigation, 1998
- Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammationPharmacology & Therapeutics, 1997
- Tachykinins in the gut. Part I. Expression, release and motor functionPharmacology & Therapeutics, 1997
- Neurogenic Amplification of Immune Complex InflammationScience, 1996
- [3H]LY303870, a Novel Nonpeptide Radioligand for the NK‐1 ReceptorJournal of Neurochemistry, 1996
- Cellular sites of expression of the neurokinin‐1 receptor in the rat gastrointestinal tractJournal of Comparative Neurology, 1995
- Substance P induces degranulation of mast cells and leukocyte adhesion to venular endotheliumPeptides, 1995
- Mast cell activation — a receptor‐independent mode of substance P action?FEBS Letters, 1987
- Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseasesDigestive Diseases and Sciences, 1987